HEAD AND NECK SQUAMOUS CELL CANCER
Clinical trials for HEAD AND NECK SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody EPI-326 enters first human tests for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study is testing a new drug called EPI-326 in people with advanced lung cancer (with EGFR mutations) or head & neck cancer. EPI-326 is a bispecific antibody designed to target cancer cells more precisely. The main goals are to check safety, find the right dose, a…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Jun 23, 2026 19:18 UTC
-
New hope for advanced cancers: XB010 trial begins
Disease control Recruiting nowThis early-phase study tests a new drug called XB010, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The main goals are to find a safe dose and check for early signs that the drug shrinks tumors. About…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC